HB 342, legislation that would require all controlled substance prescriptions to be e-prescribed, has been signed by Gov. Matt Bevin (R) after passing both Chambers unanimously. The law will be effective Friday, January 1, 2021, and contains exceptions similar to those in NACDS’ model language. NACDS thanks the Kentucky Retail Federation for its on-the-ground efforts to support this legislation.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Gov. Brad Little (R) signed into law HB 182 (Session Law Chapter 141) that eliminates the requirement that pharmacist’s prescriptive authority for specific drugs, drug categories or devices has to be granted through the Board of Pharmacy’s rulemaking authority.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Philadelphia Department of Public Health recently published a letter and FAQ reminding all city pharmacies that as of January 1, 2019, they were required to stock two doses of naloxone. The requirements are the result of an Ordinance that was adopted in November 2018. Additionally, the Ordinance requires pharmacies to post signage indicating that naloxone is available. For additional information, contact dph.opioid@phila.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Legislation requiring all controlled substances to be prescribed electronically has also advanced in Kentucky. HB 342, sponsored by pharmacist Rep. Steve Sheldon (R), passed both chambers and is currently on Gov. Matt Bevin’s (R) desk for his signature. The bill contains exemptions similar to NACDS’ model language and would be effective January 1, 2021. NACDS appreciates the on-the-ground efforts of the Kentucky Retail Association on this important bill.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The House Health Committee unanimously voted last week to amend e-prescribing language into SB 176. The bill would require all controlled substance prescriptions to be transmitted electronically effective January 1, 2021. The bill contains similar exceptions to NACDS’ model language. Additionally, the amended bill contains language requiring a summer study of e-prescribing for all prescriptions. NACDS continues to support the on-the-ground efforts of the Indiana Retail Council to advance it.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Last week, the House of Delegates passed SB 369, legislation that updates the state’s generic dispensing law to clarify that when a pharmacist substitutes a generic drug for a brand name drug, the patient pays only the cost of the substituted drug. The legislation would not apply to an individual who has insurance coverage. It is now eligible to be sent to Gov. Jim Justice (R) for signature.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Gov. Kristi Noem (R) signed into law HB 1137 effective Monday, July 1. Among its provisions, the measure prohibits pharmacy benefit managers from collecting cost-sharing in a great amount than the covered individual would pay for the drug. It also prohibits pharmacy benefit managers from retroactively adjusting a pharmacy claim unless it is a result of an audit or a technical billing error.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
Gov. Pete Ricketts (R) signed into law LB 442, facilitating medication synchronization, a priority issue for NACDS’ members
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
On March 6, NACDS testified at the Senate Seniors, Families and Children Committee in support of SB 262, legislation that would require e-prescribing of all drugs consistent with NACDS’ model legislation. Discussion continues among legislators and other concerned stakeholders about potential amendments.